These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16981713)

  • 1. Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.
    Zameer A; Schulz P; Wang MS; Sierks MR
    Biochemistry; 2006 Sep; 45(38):11532-9. PubMed ID: 16981713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
    Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
    Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells.
    Zameer A; Kasturirangan S; Emadi S; Nimmagadda SV; Sierks MR
    J Mol Biol; 2008 Dec; 384(4):917-28. PubMed ID: 18929576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toxicity of beta-amyloid is attenuated by interaction with its specific human scFv E3 in vitro.
    Yue S; Li Y; Wang X; Bai H; Xia J; Jiang L; Ji Y; Fan L; He Z; Chen Q
    Life Sci; 2008 Jun; 82(25-26):1249-55. PubMed ID: 18505701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
    Kanapathipillai M; Lentzen G; Sierks M; Park CB
    FEBS Lett; 2005 Aug; 579(21):4775-80. PubMed ID: 16098972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity.
    Liu R; McAllister C; Lyubchenko Y; Sierks MR
    Biochemistry; 2004 Aug; 43(31):9999-10007. PubMed ID: 15287727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42.
    Liu R; Barkhordarian H; Emadi S; Park CB; Sierks MR
    Neurobiol Dis; 2005 Oct; 20(1):74-81. PubMed ID: 16137568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of beta-amyloid peptide aggregation and neurotoxicity by alpha-d-mannosylglycerate, a natural extremolyte.
    Ryu J; Kanapathipillai M; Lentzen G; Park CB
    Peptides; 2008 Apr; 29(4):578-84. PubMed ID: 18304694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity.
    Feng Y; Yang SG; Du XT; Zhang X; Sun XX; Zhao M; Sun GY; Liu RT
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1250-4. PubMed ID: 19878655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
    Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
    Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
    Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
    Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P
    Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human single chain Fv antibodies and a complementarity determining region-derived peptide binding to amyloid-beta 1-42.
    Manoutcharian K; Acero G; Munguia ME; Becerril B; Massieu L; Govezensky T; Ortiz E; Marks JD; Cao C; Ugen K; Gevorkian G
    Neurobiol Dis; 2004 Oct; 17(1):114-21. PubMed ID: 15350972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.